SCHEMBL22102443

SCHEMBL22102443

CC(C)N1CCN(CC2CCN(C3CCN(C)CC3)C2)CC1

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 1/20 0.34
CACNA1B Q00975 1/20 0.34
CACNB1 Q02641 1/20 0.34
CACNA1C Q13936 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HRH3 Q9Y5N1 2/20 0.33
NCF1 P14598 1/20 0.33
CCR2 P41597 6/20 0.32
POLB P06746 1/20 0.32
KDM1A O60341 1/20 0.32
KCNH2 Q12809 4/20 0.31
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23598175 0.86 CACNA2D1 (0.37) CACNA2D1CACNA1BCACNB1CACNA1CALDH1A1
SCHEMBL27323574 0.86 CACNA2D1 (0.37) CACNA2D1CACNA1BCACNB1CACNA1CALDH1A1
SCHEMBL25565564 0.86 CACNA2D1 (0.37) CACNA2D1CACNA1BCACNB1CACNA1CALDH1A1
SCHEMBL25122598 0.85 CACNA2D1 (0.39) CACNA2D1CACNA1BCACNB1CACNA1CALDH1A1
SCHEMBL25856312 0.85 HRH3 (0.40) CACNA2D1CACNA1BCACNB1CACNA1CHRH3
SCHEMBL10092712 0.84 CACNA2D1 (0.43) CACNA2D1CACNA1BCACNB1CACNA1CALDH1A1
SCHEMBL21473688 0.81 ALDH1A1 (0.38) CACNA2D1CACNA1BCACNB1CACNA1CALDH1A1
SCHEMBL27012457 0.80 CCR2 (0.37) HRH3CCR2POLBKCNH2MEN1
SCHEMBL24204398 0.79 NCF1 (0.41) CACNA2D1CACNA1BCACNB1CACNA1CALDH1A1
SCHEMBL24236669 0.79 ALDH1A1 (0.42) ALDH1A1HRH3NCF1CCR2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020123453-A2 ALK5 INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2020-06-18 WO disclosed